Robert A. Gross, MD, PhD, FAAN, will become the interim Editor-in-Chief of its medical journal Neurology®, the world's leading clinical neurology journal. Gross, who is with University of Rochester Medical Center in Rochester, New York, will replace John H. Noseworthy, MD, FAAN, who recently resigned from the position to become president and CEO of the Mayo Clinic.
Prior to accepting the position, Gross served as Neurology's Deputy Editor-in-Chief and on the publication's Editorial Board for eight years. Gross is currently Director of the Strong Epilepsy Center and Professor of Neurology and of Physiology and Pharmacology at the University of Rochester Medical Center. He is a Fellow of the AAN and has been a member since 1984.
"It is my distinct honor to guide Neurology following the journal's continued success under Dr. Noseworthy's insightful and strategic direction. He has helped to position Neurology as the premiere publication for disseminating cutting-edge, peer-reviewed information to the neurology community worldwide," said Gross. "Under my leadership, we will continue to focus on providing busy office neurologists, residents and trainees, academic neurologists and researchers with convenient access to the latest information in order to advance neurology-focused patient care."
Neurology is the world's most widely read and highly cited, peer-reviewed neurology journal and receives nearly 4,000 manuscript submissions annually, with about 66 percent of those coming from international researchers. Readers now enjoy Italian, Japanese, Polish, Spanish, Turkish, Korean, Chinese, and English editions of Neurology.
Disclaimer: The opinions expressed in this posting are those of the author only and do not represent the views of the American Academy of Neurology or any of its affiliated subsidiaries.
Please login to view and submit comments.